ARTICLE | Clinical News
Myozyme alglucosidase alfa regulatory update
March 2, 2009 8:00 AM UTC
The EC approved an MAA from Genzyme for Myozyme alglucosidase produced in a 4,000 liter-bioreactor to treat Pompe's disease. Genzyme said the product would be launched immediately. In January, Genzyme...